Your session is about to expire
← Back to Search
Blood Glucose Monitoring for Gestational Diabetes
N/A
Waitlist Available
Led By Stephen Chasen, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Pregnant patients with singleton gestation who are ≥ 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time of delivery
Awards & highlights
Study Summary
This trial will help researchers understand if gestational diabetics who perform 1-hour postprandial blood glucose testing are more likely to adhere to their treatment plan than those who perform 2-hour postprandial blood glucose testing.
Who is the study for?
This trial is for pregnant women over 18 with a single pregnancy, diagnosed with gestational diabetes (GDM) after 24 weeks using the two-step screening method. It's not for those who had GDM before 24 weeks or have pre-gestational Type 1 or Type 2 diabetes.Check my eligibility
What is being tested?
The study compares how well patients with GDM stick to blood sugar testing if they check it one hour versus two hours after eating. The goal is to see which timing leads to better adherence in completing glucose logs.See study design
What are the potential side effects?
Since this trial involves standard blood glucose monitoring, there are no direct side effects from interventions like drugs; however, participants may experience discomfort from frequent finger pricks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am pregnant with one baby and am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at time of delivery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of delivery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of adherence
Secondary outcome measures
Medication Therapy Management
Neonatal birthweight
Number of NICU admissions
+19 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: 2-hour post-prandial blood glucose monitoring ArmExperimental Treatment1 Intervention
Arm in which participants are randomized to blood glucose monitoring at 2 hours after eating.
Group II: 1-hour post-prandial blood glucose monitoring ArmExperimental Treatment1 Intervention
Arm in which participants are randomized to blood glucose monitoring at 1 hour after eating.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,052 Previous Clinical Trials
1,329,732 Total Patients Enrolled
Stephen Chasen, MDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
34 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You were diagnosed with gestational diabetes after being 24 weeks pregnant.I have had Type 1 diabetes before becoming pregnant.You were diagnosed with gestational diabetes before reaching 24 weeks of pregnancy.I have type 2 diabetes and had it before getting pregnant.I am pregnant with one baby and am 18 years old or older.You have been diagnosed with gestational diabetes using the screening guidelines from the American College of Obstetrics and Gynecologists.
Research Study Groups:
This trial has the following groups:- Group 1: 1-hour post-prandial blood glucose monitoring Arm
- Group 2: 2-hour post-prandial blood glucose monitoring Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts currently underway for this trial?
"According to the clinicaltrials.gov page, this medical study is currently not in search of participants. It was initially posted on July 15th 2021 and subsequently revised on July 29 2022; despite its conclusion, there are presently 103 other trials seeking people's participation."
Answered by AI
Share this study with friends
Copy Link
Messenger